Cargando…

High Eg5 expression predicts poor prognosis in breast cancer

Eg5 is a motor protein belonging to the kinesin-5 family and has been suggested to exert important function in tumors. In this study, we determined the mRNA and protein expression levels of Eg5 in cancerous and non-cancerous breast tissue by quantitative real-time polymerase chain reaction (qRT-PCR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Qin, Huang, Fang, Wang, Xudong, Zhu, Huijun, Xian, Yun, Li, Jieying, Zhang, Shu, Ni, Qichao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617498/ https://www.ncbi.nlm.nih.gov/pubmed/28977938 http://dx.doi.org/10.18632/oncotarget.19215

Ejemplares similares

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

LAMP1 expression is associated with poor prognosis in breast cancer
por: Wang, Qingqing, et al.
Publicado: (2017)

High expression levels of Wnt5a and Ror2 in laryngeal squamous cell carcinoma are associated with poor prognosis
por: Zhang, Wei, et al.
Publicado: (2017)

Decreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer
por: Li, Jieying, et al.
Publicado: (2016)

HSP70 regulates Eg5 distribution within the mitotic spindle and modulates the cytotoxicity of Eg5 inhibitors
por: Fang, Chieh-Ting, et al.
Publicado: (2020)

High methionyl–tRNA synthetase expression predicts poor prognosis in patients with breast cancer
por: Jin, Qin, et al.
Publicado: (2020)

Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
por: Xian, Yun, et al.
Publicado: (2016)

Eg5 steps it up!
por: Valentine, Megan T, et al.
Publicado: (2006)

Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer
por: Yao, Juan, et al.
Publicado: (2017)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
por: Huang, Jianfei, et al.
Publicado: (2015)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

High Spy1 expression predicts poor prognosis in colorectal cancer
por: Jin, Qin, et al.
Publicado: (2018)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT
por: Feng, Jian, et al.
Publicado: (2012)

TPX2 is a drag on Eg5
por: Leslie, Mitch
Publicado: (2011)

Nuclear Eg5 (kinesin spindle protein) expression predicts docetaxel response and prostate cancer aggressiveness
por: Wissing, Michel D., et al.
Publicado: (2014)

Trop2 is overexpressed in gastric cancer and predicts poor prognosis
por: Zhao, Wei, et al.
Publicado: (2015)

Decreased expression of SCARA5 predicts a poor prognosis in melanoma using bioinformatics analysis
por: Ni, Qinggan, et al.
Publicado: (2023)

Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer
por: Lu, Chenlin, et al.
Publicado: (2015)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Prognostic Value of Rab27B Nuclear Expression in Gastrointestinal Stromal Tumors
por: Wang, Wei, et al.
Publicado: (2014)

Sperm-associated antigen 5 is a potential biomarker for poor prognosis in breast cancer
por: Zhou, Xiaoli, et al.
Publicado: (2019)

Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients
por: Gu, Xiaobin, et al.
Publicado: (2016)

The structure of the ternary Eg5–ADP–ispinesib complex
por: Talapatra, S. K., et al.
Publicado: (2012)

5th EGS4 Users' Meeting in Japan
por: Ban, S, et al.
Publicado: (1995)

Non‐canonical functions of the mitotic kinesin Eg5
por: Liu, Min, et al.
Publicado: (2018)

Insights into the Molecular Mechanisms of Eg5 Inhibition by (+)-Morelloflavone
por: Ogunwa, Tomisin Happy, et al.
Publicado: (2019)

High expression of Linc00959 predicts poor prognosis in breast cancer
por: Chi, Weiru, et al.
Publicado: (2019)

TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis
por: Liu, Fang, et al.
Publicado: (2016)

Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2021)

Increased expression of SYCP2 predicts poor prognosis in patients suffering from breast carcinoma
por: Zheng, Hongyan, et al.
Publicado: (2022)

EGS4 shower display system, EGS4PICT(2), windows version
por: Hirayama, H, et al.
Publicado: (1994)

The Role of MbEGS1 and MbEGS2 in Methyleugenol Biosynthesis by Melaleuca bracteata
por: Lin, Yongsheng, et al.
Publicado: (2023)

LINC00978 predicts poor prognosis in breast cancer patients
por: Deng, Lin-lin, et al.
Publicado: (2016)

Evaluation of Immunogenicity of Novel Isoform of EG95 (EG95-5G1) From Echinococcus granulosus in BALB/C Mice
por: PIRESTANI, Majid, et al.
Publicado: (2014)

Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer
por: Lian, Shuijin, et al.
Publicado: (2016)

Kinetochore-microtubule stability governs the metaphase requirement for Eg5
por: Gayek, A. Sophia, et al.
Publicado: (2014)

High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Xu, Wenxiong, et al.
Publicado: (2022)

EGS4 Benchmark program
por: Yasu, Y, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_mujgt3k6farogla454tlin9knc